Prof. Xinglong Zhong, Department of Cardiology, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers’ Hospital, China
Prof. Xinglong Zhong is a dedicated cardiologist specializing in the diagnosis and treatment of cardiovascular diseases, with expertise in independent coronary angiography. 🏥 His clinical practice is complemented by a strong research background, focusing on vascular aging, myocardial fibrosis, and vascular calcification. 🔬 He has co-authored multiple peer-reviewed papers in prestigious SCI-indexed journals and has accumulated 244 citations with a top paper cited 127 times. 📊 His innovative work bridges interventional cardiology and molecular research, positioning him as a rising figure in cardiovascular science and precision medicine. 🌐❤️ His efforts continue to advance heart health through scientific discovery.
Publication Profile
Orcid
Education
Prof. Xinglong Zhong 🫀 is a skilled cardiologist specializing in the diagnosis and treatment of cardiovascular diseases, with particular expertise in independent coronary angiography. 🏥 His clinical proficiency is matched by a strong foundation in research, enabling him to bridge hands-on patient care with scientific innovation. 🔬 He has co-authored several peer-reviewed articles published in SCI-indexed journals, contributing valuable insights into vascular health and cardiology. 📚 His work exemplifies a harmonious integration of advanced interventional cardiology and active academic engagement, making him a vital contributor to both clinical excellence and medical research.
Professional Memberships
Prof. Xinglong Zhong 🩺 is currently not affiliated with any professional memberships or academic societies. While he does not hold formal memberships, his impactful research contributions and clinical expertise in cardiology speak volumes about his dedication to the field. 📚🧬 His work continues to gain recognition through high-quality publications and citation metrics, reflecting his independent commitment to advancing cardiovascular science. 🚀🔬 Despite the absence of organizational affiliations, Prof. Zhong remains a respected figure in both research and clinical communities, demonstrating that consistent innovation and scholarly excellence can shine through individual initiative and professional dedication.
Research Focus
Prof. Xinglong Zhong’s research focus lies in cardiovascular pathophysiology, with a special emphasis on vascular calcification, myocardial fibrosis, and molecular mechanisms of aging in chronic kidney disease. 🔍 His work explores the impact of gut-derived metabolites like trimethylamine-N-oxide (TMAO), inflammatory signaling pathways (NF-κB, NLRP3), and therapeutic agents such as puerarin and dihydromyricetin. 💊 He also investigates cutting-edge strategies like supramolecular hydrogels for cellular senescence and novel concepts like ion therapy in myocardial infarction. 🧪 His multidisciplinary approach bridges molecular cardiology and regenerative therapy, advancing precision treatment in heart and vascular diseases.
Publication Top Notes
- Trimethylamine-N-oxide promotes vascular aging via inhibiting GATA4 degradation in chronic kidney disease rats
- Enhanced fibrotic potential of COL1A1hiNR4A1low fibroblasts in ischemic heart revealed by transcriptional dynamics heterogeneity analysis at both bulk and single-cell levels
- Lactobacillus rhamnosus GG aggravates vascular calcification in chronic kidney disease: A potential role for extracellular vesicles
- Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling
- Puerarin Alleviates Lipopolysaccharide-Induced Myocardial Fibrosis by Inhibiting PARP-1 to Prevent HMGB1-Mediated TLR4-NF-κB Signaling Pathway
- Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals
- β-Galactosidase instructed supramolecular hydrogelation for selective identification and removal of senescent cells
-
CDC42 promotes vascular calcification in chronic kidney disease